4'-fluoro-α-Pyrrolidinopropiophenone (hydrochloride)
(Synonyms: 4'-fluoro-α-PPP) 目录号 : GC46655A neuropeptide with diverse biological activities
Cas No.:2748590-18-1
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
The α-pyrrolidinophenones (α-
1.Springer, D., Fritschi, G., and Maurer, H.Metabolism of the new designer drug α-pyrrolidinoproppiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-α-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometryJournal of Chromatography.B, Analytical Technologies in the Biomedical and Life Sciences796(2)253-266(2003) 2.Brandt, S.D., Freeman, S., Sumnall, H.R., et al.Analysis of NRG 'legal highs' in the UK: Identification and formation of novel cathinonesDrug Test.Anal.3(9)569-575(2011) 3.Kikura-Hanajiri, R., Uchiyama, N., and Goda, Y.Survey of current trends in the abuse of psychotropic substances and plants in JapanLeg. Med. (Tokyo)13(3)109-115(2011) 4.Staack, R.F., and Maurer, H.H.Metabolism of designer drugs of abuseCurr. Drug Metab.6(3)259-274(2005)
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.8805 mL | 19.4024 mL | 38.8048 mL |
5 mM | 0.7761 mL | 3.8805 mL | 7.761 mL |
10 mM | 0.388 mL | 1.9402 mL | 3.8805 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。